Morgan Stanley (NYSE:MS) raised its view on the US IT Services sector to In-Line from Cautious, citing a more balanced ...
Bristol Myers Squibb today announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended approval of Breyanzi® (lisocabtagene maraleucel; ...
Dealmakers at law firm Hugh James have said it "remains positive" for the year ahead after another record-breaking 2024.